Krajina: Írsko
Jazyk: angličtina
Zdroj: HPRA (Health Products Regulatory Authority)
Acetylsalicylic acid
KRKA, d.d., Novo mesto
B01AC; B01AC06
Acetylsalicylic acid
75 milligram(s)
Gastro-resistant tablet
Product subject to prescription which may be renewed (B)
Platelet aggregation inhibitors excl. heparin; acetylsalicylic acid
Marketed
2017-03-10
PACKAGE LEAFLET: INFORMATION FOR THE USER ASPIRIN KRKA 75 MG GASTRO-RESISTANT TABLETS acetylsalicylic acid READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Aspirin Krka is and what it is used for 2. What you need to know before you take Aspirin Krka 3. How to take Aspirin Krka 4. Possible side effects 5. How to store Aspirin Krka 6. Contents of the pack and other information 1. WHAT ASPIRIN KRKA IS AND WHAT IT IS USED FOR Aspirin Krka contains acetylsalicylic acid, which in low doses belong to a group of medicines called anti-platelet agents. Platelets are tiny cells in the blood that cause the blood to clot and are involved in thrombosis. When a blood clot occurs in an artery it stops the blood flowing and cuts off the oxygen supply. When this happens in the heart it can cause a heart attack or angina; in the brain it can cause a stroke. Aspirin Krka is taken to reduce the risk of blood clots forming and thereby prevent further: - heart attacks - strokes - cardiovascular problems in patients who suffer from stable or unstable angina (a type of chest pain). Aspirin Krka is also used to prevent the formation of blood clots after certain types of heart surgery in order to widen or to unblock the blood vessels. This medicinal product is not recommended for emergencies. It can only be used as a preventive treatment. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ASPIRIN KRKA DO NOT TAKE ASPIRIN KRKA: - if you are allergic to acetylsalicylic acid or any of the other ingredients of this medicine (listed in s Prečítajte si celý dokument
Health Products Regulatory Authority 16 March 2023 CRN00C87S Page 1 of 10 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Aspirin Krka 75 mg gastro-resistant tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each gastro-resistant tablet contains 75 mg acetylsalicylic acid. Excipients with known effect: Lactose monohydrate......................................................................................... 45 mg per tablet. Sunset yellow (E110).................................................................................. 0.0006 mg per tablet. For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Gastro-resistant tablet Pink, round biconvex film-coated tablets with a diameter of about 7.2 mm. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS - Secondary prevention of myocardial infarction. - Prevention of cardiovascular morbidity in patients suffering from stable angina pectoris. - History of unstable angina pectoris, except during the acute phase. - Prevention of graft occlusion after Coronary Artery Bypass Grafting (CABG). - Coronary angioplasty, except during the acute phase. - Secondary prevention of transient ischaemic attacks (TIA) and ischaemic cerebrovascular accidents (CVA), provided intracerebral haemorrhages have been ruled out Aspirin Krka is not recommended in emergency situations. It is restricted to secondary prevention with chronic treatment. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Adults_ _Secondary prevention of myocardial infarction:_ The recommended dose is 75-160 mg once daily. _Prevention of cardiovascular morbidity in patients suffering from stable angina pectoris:_ The recommended dose is 75-160 mg once daily. _History of unstable angina pectoris, except during the acute phase:_ The recommended dose is 75-160 mg once daily. _Prevention of graft occlusion after Coronary Artery Bypass Grafting (CABG):_ The recommended dose is 75-160 mg once daily. Health Products Regulatory Authority 16 March 2023 CRN00C87S Page 2 of 10 _Coronary angiop Prečítajte si celý dokument